Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,507 | 82 | 97.4% |
| Education | $40.19 | 2 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $356.91 | 23 | $0 (2024) |
| Amgen Inc. | $161.50 | 8 | $0 (2024) |
| Allergan, Inc. | $155.71 | 9 | $0 (2020) |
| AMAG Pharmaceuticals, Inc. | $136.83 | 2 | $0 (2018) |
| Lilly USA, LLC | $132.94 | 7 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $112.32 | 7 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $53.08 | 2 | $0 (2023) |
| TherapeuticsMD, Inc. | $49.54 | 4 | $0 (2019) |
| MILLICENT US INC | $46.88 | 2 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $34.71 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $269.80 | 14 | ABBVIE INC. ($81.69) |
| 2023 | $396.87 | 24 | AbbVie Inc. ($188.75) |
| 2022 | $180.80 | 10 | Lilly USA, LLC ($91.68) |
| 2020 | $146.72 | 7 | Amgen Inc. ($87.06) |
| 2019 | $209.70 | 14 | TherapeuticsMD, Inc. ($49.54) |
| 2018 | $257.86 | 9 | AMAG Pharmaceuticals, Inc. ($123.34) |
| 2017 | $85.73 | 6 | Allergan Inc. ($43.56) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | MILLICENT US INC | — | Education | In-kind items and services | $26.70 | General |
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Endocrinology | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Gastroenterology | ||||||
| 03/29/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Surgical Care | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Respiratory | ||||||
| 03/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Bone Health | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Gastroenterology | ||||||
| 01/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/19/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: UROLOGY | ||||||
| 11/22/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Gastroenterology | ||||||
| 08/10/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: INSOMNIA | ||||||
| 06/22/2023 | Becton, Dickinson and Company | BD Affirm VPIII Microbial Identification Test (Device) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Cell Analyzers | ||||||
| 06/12/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 295 | 305 | $54,231 | $16,190 |
| 2022 | 7 | 296 | 304 | $52,505 | $15,973 |
| 2021 | 8 | 297 | 304 | $54,772 | $16,890 |
| 2020 | 7 | 287 | 297 | $60,131 | $15,804 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 63 | $12,600 | $3,850 | 30.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $12,432 | $3,090 | 24.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 79 | 79 | $8,216 | $3,049 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 18 | $5,328 | $1,814 | 34.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 42 | 42 | $5,166 | $1,790 | 34.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 38 | 38 | $7,752 | $1,707 | 22.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 23 | $2,737 | $890.21 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 63 | $12,600 | $4,037 | 32.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 79 | 79 | $8,216 | $3,077 | 37.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $11,248 | $2,803 | 24.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 34 | 34 | $6,936 | $1,672 | 24.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 36 | 40 | $4,760 | $1,551 | 32.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 35 | 35 | $4,305 | $1,489 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $4,440 | $1,345 | 30.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 92 | 92 | $9,568 | $3,585 | 37.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 51 | $10,200 | $3,423 | 33.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 39 | 39 | $11,544 | $2,943 | 25.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 19 | $5,624 | $1,803 | 32.1% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 33 | 33 | $6,732 | $1,745 | 25.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 32 | 32 | $3,936 | $1,374 | 34.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 24 | $2,856 | $1,029 | 36.0% |
| 58100 | Biopsy of uterine lining | Office | 2021 | 14 | 14 | $4,312 | $986.88 | 22.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 48 | $14,208 | $3,741 | 26.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 91 | 91 | $9,464 | $3,590 | 37.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 47 | 47 | $13,912 | $2,917 | 21.0% |
About Dr. Stacey Yell, MD
Dr. Stacey Yell, MD is a Gynecology healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124124193.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacey Yell, MD has received a total of $1,547 in payments from pharmaceutical and medical device companies, with $269.80 received in 2024. These payments were reported across 84 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,507).
As a Medicare-enrolled provider, Yell has provided services to 1,175 Medicare beneficiaries, totaling 1,210 services with total Medicare billing of $64,857. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Gynecology
- Location Tucson, AZ
- Active Since 09/16/2006
- Last Updated 09/13/2021
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1124124193
Products in Payments
- QULIPTA (Drug) $163.45
- EVENITY (Biological) $144.68
- INTRAROSA (Drug) $136.83
- XIFAXAN (Drug) $92.50
- LILETTA (Drug) $87.41
- EMGALITY (Drug) $83.83
- UBRELVY (Drug) $75.80
- GEMTESA (Drug) $53.08
- LO LOESTRIN FE (Drug) $44.88
- Lupron (Drug) $42.18
- CREON (Drug) $37.79
- IMVEXXY (Drug) $36.76
- NURTEC ODT (Drug) $34.71
- QUVIVIQ (Drug) $29.30
- JARDIANCE (Drug) $27.79
- Orilissa (Drug) $25.84
- CAPLYTA (Drug) $23.83
- ON-Q PUMP AND ACCESSORIES (Device) $22.79
- BD Affirm VPIII Microbial Identification Test (Device) $22.73
- MOUNJARO (Drug) $21.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Tucson
Dr. Walter Patton, Md, MD
Gynecology — Payments: $2,782
Linda Turner, Md, MD
Gynecology — Payments: $1,636
Dr. Robert Kahler, Md, MD
Gynecology — Payments: $1,104
Dr. Karen Addis, Md, MD
Gynecology — Payments: $819.12
Jaime Ledesma, Md, MD
Gynecology — Payments: $614.84
Marilyn Medwied, Md, MD
Gynecology — Payments: $393.66